Critically, Maurus and others demonstrated that FOSL1 promotes anoikis resistant growth of melanoma cells on soft agar, and allows subcutaneous tumour growth in vivo via a Fra-1 target gene product, the chromatin modifier HMGA1 (Maurus et al., 2017). This evidence concerns the gene FOSL1 and melanoma.